Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory…

Overview of attention for article published in Haematologica, November 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

twitter: 6 X users

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 7 X posts from 6 X users, with an upper bound of 27,371 followers.

RT @geltamo: Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE…

Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma | Haematologica https://t.co/JkzZiU7RgS

RT @Haematologica: Read here a comparison of results from the mosunetuzumab phase I/II trial to historical outcomes from a real-life cohort…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 3 additional X posts.